← All Companies
Biohaven Ltd.
BHVN · NYSE · SIC 2834: Pharmaceutical Preparations
Business Summary Overview Biohaven is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. We are advancing our innovative portfolio of therapeutics, leveraging our proven drug development experience and multiple proprietary drug development platforms. On October 3, 2022, Biohaven Pharmaceutical Holding Company Ltd. (the Former Parent) completed the distribution to holders o...
Next Earnings Q2 FY2026 — expected 2026-08-16
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention BHVN discussed_in_filing Cybersecurity topic_mention BHVN discussed_in_filing Trusted Computing topic_mention BHVN discussed_in_filing Blockchain & Crypto topic_mention BHVN discussed_in_filing Regulation topic_mention BHVN discussed_in_filing Healthcare & Bio topic_mention BHVN discussed_in_filing Platform & Ecosystem topic_mention BHVN discussed_in_filing Sovereign & Government topic_mention BHVN discussed_in_filing Cybersecurity topic_mention BHVN discussed_in_filing Trusted Computing topic_mention BHVN discussed_in_filing Blockchain & Crypto topic_mention BHVN discussed_in_filing Regulation topic_mention BHVN discussed_in_filing Healthcare & Bio topic_mention BHVN discussed_in_filing Platform & Ecosystem topic_mention BHVN discussed_in_filing Sovereign & Government topic_mention BHVN discussed_in_filing Cybersecurity topic_mention BHVN discussed_in_filing Trusted Computing topic_mention BHVN discussed_in_filing Blockchain & Crypto topic_mention BHVN discussed_in_filing Regulation topic_mention BHVN discussed_in_filing Healthcare & Bio topic_mention BHVN discussed_in_filing Platform & Ecosystem
Annual Reports (10-K) Filed Period Accession Source Full Text 2026-03-02 2025-12-31 0001935979-26-000020 EDGAR 103K words 2025-03-03 2024-12-31 0001935979-25-000015 EDGAR — 2024-02-29 2023-12-31 0001935979-24-000010 EDGAR — 2023-03-23 2022-12-31 0001935979-23-000009 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-11-10 2025-09-30 0001935979-25-000092 EDGAR 35K words 2025-08-11 2025-06-30 0001935979-25-000068 EDGAR — 2025-05-12 2025-03-31 0001935979-25-000054 EDGAR — 2024-11-12 2024-09-30 0001935979-24-000085 EDGAR — 2024-08-09 2024-06-30 0001935979-24-000069 EDGAR — 2024-05-09 2024-03-31 0001935979-24-000046 EDGAR — 2023-11-14 2023-09-30 0001935979-23-000062 EDGAR — 2023-07-31 2023-06-30 0001935979-23-000052 EDGAR — 2023-05-12 2023-03-31 0001935979-23-000029 EDGAR — 2022-11-09 2022-09-30 0001935979-22-000011 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-03-02 0001935979-26-000022 EDGAR 7K words 2026-01-12 0001935979-26-000005 EDGAR — 2026-01-07 0001935979-26-000002 EDGAR — 2025-11-13 0001628280-25-052066 EDGAR — 2025-11-10 0001935979-25-000090 EDGAR — 2025-08-22 0001935979-25-000080 EDGAR — 2025-08-15 0001935979-25-000074 EDGAR — 2025-08-11 0001935979-25-000067 EDGAR — 2025-06-04 0001935979-25-000058 EDGAR — 2025-05-15 0001935979-25-000056 EDGAR —
74 total filings indexed. 50 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001935979
Ticker BHVN
Exchange NYSE
SIC 2834: Pharmaceutical Preparations
Incorporated D8
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 03be96c1474609d957cf93a2b1766fd7f28a5c6a332046eb1ee303dc597e98be
parent: 958dcc9122ca0c66636bae63bb8465d2c8d560a5645e453c92147022e017ab2d
content hash: 1ebc334074960e75d3babc24d0e2157c4af2853e26ffb97c3e0c23f26f1343c1
signed: 2026-04-13T04:43:57.902Z
sources: 14 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf